Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation

BACKGROUND: Warfarin is the most prescribed oral anticoagulant used for preventing stroke in patients with atrial fibrillation. Time in the therapeutic range (TTR) has been accepted as the best method to evaluate the quality of warfarin therapy. The main aim of the present study was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcatto, Leiliane Rodrigues, Sacilotto, Luciana, da Costa Darrieux, Francisco Carlos, Hachul, Denise Tessariol, Scanavacca, Maurício Ibrahim, Krieger, Jose Eduardo, Pereira, Alexandre Costa, Lima Santos, Paulo Caleb Junior
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Gerotarget (Focus on Aging)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342334/
https://www.ncbi.nlm.nih.gov/pubmed/27486984
http://dx.doi.org/10.18632/oncotarget.10944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342334/
https://www.ncbi.nlm.nih.gov/pubmed/27486984
http://dx.doi.org/10.18632/oncotarget.10944

Ejemplares similares